Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Kechagias S" with an ORCID

Stergios Kechagias
Linköpings universitet
52
Publications
4,020
Citations
View profile

Search results

1-25 of 126 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Forty years of successful national research collaboration in liver disease - the Swedish experience.
Bergquist A, Ekstedt M, Hagström H, Järnerot G, Lindgren S, Nilsson E, Nyhlin N, Rorsman F, Stål P, Werner M, Swehep, Kechagias S
Scand J Gastroenterol, 1-8, 01 Nov 2024
Cited by: 0 articles | PMID: 39485016
Add to export list Review
Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD.
Shang Y, Akbari C, Dodd M, Nasr P, Vessby J, Rorsman F, Kechagias S, Stål P, Ekstedt M, Hagström H
Gut, 73(11):e30, 07 Oct 2024
Cited by: 0 articles | PMID: 38408839
Add to export list
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease.
Shang Y, Akbari C, Dodd M, Zhang X, Wang T, Jemielita T, Fernandes G, Engel SS, Nasr P, Vessby J, Rorsman F, Kechagias S, Stål P, Ekstedt M, Hagström H
Hepatology, 07 Aug 2024
Cited by: 0 articles | PMID: 39110990
Add to export list
Wireless implantable bioelectronics with a direct electron transfer lactate enzyme for detection of surgical site infection in orthopaedics.
Gil B, Hall TAG, Freeman DME, Ming D, Kechagias S, Nabilla S, Cegla F, van Arkel RJ
Biosens Bioelectron, 263:116571, 14 Jul 2024
Cited by: 1 article | PMID: 39047650
Add to export list
Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD.
Hegmar H, Wiggers T, Nasr P, Vessby J, Kechagias S, Nyhlin N, Marschall HU, Borssén ÅD, Strandberg R, Karsdal M, Leeming DJ, Ekstedt M, Hagström H
J Intern Med, 296(2):177-186, 03 Jul 2024
Cited by: 1 article | PMID: 38959258
Add to export list
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).
Vacca M, Kamzolas I, Harder LM, Oakley F, Trautwein C, Hatting M, Ross T, Bernardo B, Oldenburger A, Hjuler ST, Ksiazek I, Lindén D, Schuppan D, Rodriguez-Cuenca S, Tonini MM, Castañeda TR, Kannt A, Rodrigues CMP, Cockell S, [...] Vidal-Puig A
Nat Metab, 6(6):1178-1196, 12 Jun 2024
Cited by: 12 articles | PMID: 38867022 | PMCID: PMC11199145
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.
Jönsson C, Bergram M, Kechagias S, Nasr P, Ekstedt M
Scand J Gastroenterol, 59(6):737-741, 02 Apr 2024
Cited by: 0 articles | PMID: 38563432
Add to export list
A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth.
Podéus H, Simonsson C, Nasr P, Ekstedt M, Kechagias S, Lundberg P, Lövfors W, Cedersund G
NPJ Digit Med, 7(1):112, 03 May 2024
Cited by: 0 articles | PMID: 38702474
Add to export list
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Armandi A, Sanavia T, Younes R, Caviglia GP, Rosso C, Govaere O, Liguori A, Francione P, Gallego-Duràn R, Ampuero J, Pennisi G, Aller R, Tiniakos D, Burt A, David E, Vecchio F, Maggioni M, Cabibi D, McLeod D, [...] Bugianesi E
Gut, 73(5):825-834, 05 Apr 2024
Cited by: 3 articles | PMID: 38199805
Add to export list
The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM).
Cornillet M, Villard C, Rorsman F, Molinaro A, Nilsson E, Kechagias S, von Seth E, Bergquist A
EClinicalMedicine, 70:102526, 11 Mar 2024
Cited by: 1 article | PMID: 38500838 | PMCID: PMC10945116
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A physiologically-based digital twin for alcohol consumption—predicting real-life drinking responses and long-term plasma PEth
Podéus H, Simonsson C, Nasr P, Ekstedt M, Kechagias S, Lundberg P, Lövfors W, Cedersund G
NPJ Digit Med, 7(1), 01 Jan 2024
Cited by: 0 articles | PMCID: PMC11068902
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.
Nasr P, Wester A, Ekstedt M, Strandberg R, Kechagias S, Shang Y, Widman L, Hagström H
Clin Gastroenterol Hepatol, 22(5):1048-1057.e2, 17 Jan 2024
Cited by: 2 articles | PMID: 38237695
Add to export list
A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol.
Nasr P, Forsgren M, Balkhed W, Jönsson C, Dahlström N, Simonsson C, Cai S, Cederborg A, Henriksson M, Stjernman H, Rejler M, Sjögren D, Cedersund G, Bartholomä W, Rydén I, Lundberg P, Kechagias S, Leinhard OD, Ekstedt M
BMC Gastroenterol, 23(1):454, 21 Dec 2023
Cited by: 0 articles | PMID: 38129794 | PMCID: PMC10734181
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD.
Akbari C, Dodd M, Stål P, Nasr P, Ekstedt M, Kechagias S, Vessby J, Rorsman F, Zhang X, Wang T, Jemielita T, Fernandes G, Engel SS, Hagström H, Shang Y
JHEP Rep, 6(2):100915, 25 Sep 2023
Cited by: 0 articles | PMID: 38293684 | PMCID: PMC10827505
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The effect of nodal connectivity and strut density within stochastic titanium scaffolds on osteogenesis.
Kechagias S, Theodoridis K, Broomfield J, Malpartida-Cardenas K, Reid R, Georgiou P, van Arkel RJ, Jeffers JRT
Front Bioeng Biotechnol, 11:1305936, 29 Nov 2023
Cited by: 1 article | PMID: 38107615 | PMCID: PMC10721980
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.
Knöchel J, Bergenholm L, Ibrahim E, Kechagias S, Hansson S, Liljeblad M, Nasr P, Carlsson B, Ekstedt M, Ueckert S
CPT Pharmacometrics Syst Pharmacol, 12(12):2038-2049, 03 Oct 2023
Cited by: 1 article | PMID: 37750001 | PMCID: PMC10725269
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A physiologically-based digital twin for alcohol consumption – predicting real-life drinking responses and long-term plasma PEth
Podéus H, Simonsson C, Nasr P, Ekstedt M, Kechagias S, Lundberg P, Lövfors W, Cedersund G
bioRxiv, 22 Aug 2023
Cited by: 0 articles | PPR: PPR705023
Add to export list Preprint
Diagnostic value of fecal calprotectin in primary care patients with gastrointestinal symptoms: A retrospective Swedish cohort study.
Rendek Z, Falk M, Grodzinsky E, Kechagias S, Hjortswang H
JGH Open, 7(10):708-716, 22 Sep 2023
Cited by: 0 articles | PMID: 37908296 | PMCID: PMC10615176
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease.
Gruneau L, Kechagias S, Kechagias S, Sandström P, Ekstedt M, Henriksson M
Hepatol Commun, 7(7):e00191, 22 Jun 2023
Cited by: 1 article | PMID: 37347223 | PMCID: PMC10289790
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Electromechanical and biological evaluations of 0.94Bi_0.5Na_0.5TiO₃-0.06BaTiO₃ as a lead-free piezoceramic for implantable bioelectronics.
Hall TAG, Theodoridis K, Kechagias S, Kohli N, Denonville C, Rørvik PM, Cegla F, van Arkel RJ
Biomater Adv, 154:213590, 14 Aug 2023
Cited by: 2 articles | PMID: 37598437
Add to export list
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Mózes FE, Lee JA, Vali Y, Alzoubi O, Staufer K, Trauner M, Paternostro R, Stauber RE, Holleboom AG, van Dijk AM, Mak AL, Boursier J, de Saint Loup M, Shima T, Bugianesi E, Gaia S, Armandi A, Shalimar, Lupșor-Platon M, [...] LITMUS investigators
Lancet Gastroenterol Hepatol, 8(8):704-713, 05 Jun 2023
Cited by: 35 articles | PMID: 37290471
Add to export list
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Lee J, Westphal M, Westphal M, Vali Y, Boursier J, Petta S, Ostroff R, Alexander L, Chen Y, Fournier C, Geier A, Francque S, Wonders K, Tiniakos D, Bedossa P, Allison M, Papatheodoridis G, Cortez-Pinto H, Pais R, [...] LITMUS investigators
Hepatology, 78(1):258-271, 31 Mar 2023
Cited by: 6 articles | PMID: 36994719
Add to export list
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort^☆" [J Hepatol (2020) 505-515].
Anstee QM, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, Burt AD, Bedossa P, Palmer J, Liu YL, Aithal GP, Allison M, Yki-Järvinen H, Vacca M, Dufour JF, Invernizzi P, Prati D, Ekstedt M, Kechagias S, [...] EPoS Consortium Investigators
J Hepatol, 78(5):1085-1086, 13 Mar 2023
Cited by: 1 article | PMID: 36922251
Add to export list
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.
Blomdahl J, Nasr P, Ekstedt M, Kechagias S, Kechagias S
Hepatol Commun, 7(1):e0003, 10 Jan 2023
Cited by: 8 articles | PMID: 36633482 | PMCID: PMC9833449
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C, Friis-Liby I, Rorsman F, Said K, Warnqvist A, Cornillet M, Kechagias S, Nyhlin N, Werner M, Janczewska I, Hagström T, Nilsson E, Bergquist A
J Hepatol, 78(3):604-613, 19 Nov 2022
Cited by: 17 articles | PMID: 36410555
Add to export list

1-25 of 126 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Kechagias S" with an ORCID

Search results

Forty years of successful national research collaboration in liver disease - the Swedish experience.

Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD.

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease.

Wireless implantable bioelectronics with a direct electron transfer lactate enzyme for detection of surgical site infection in orthopaedics.

Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD.

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).

Activin A levels in metabolic dysfunction-associated steatotic liver disease associates with fibrosis and the PNPLA3 I148M variant.

A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth.

Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.

The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM).

A physiologically-based digital twin for alcohol consumption—predicting real-life drinking responses and long-term plasma PEth

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol.

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD.

The effect of nodal connectivity and strut density within stochastic titanium scaffolds on osteogenesis.

A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.

A physiologically-based digital twin for alcohol consumption – predicting real-life drinking responses and long-term plasma PEth

Diagnostic value of fecal calprotectin in primary care patients with gastrointestinal symptoms: A retrospective Swedish cohort study.

Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease.

Electromechanical and biological evaluations of 0.94Bi_0.5Na_0.5TiO₃-0.06BaTiO₃ as a lead-free piezoceramic for implantable bioelectronics.

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.

Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort^☆" [J Hepatol (2020) 505-515].

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD.

Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.

Partnerships & funding

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:Kechagias S" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Kechagias S" with an ORCID